Till & McCulloch and the 1961 Proof of Stem Cells
When people ask what a stem cell is, they often hear a modern definition: a cell that can renew itself and give rise to specialized descendants. That definition did not arrive fully formed from marketing copy. It grew out of careful experiments—none more foundational for blood-forming stem cells than the work of physicist James Till and physician-scientist Ernest McCulloch at Toronto’s Ontario Cancer Institute in the early 1960s.
Cold War laboratories, hematology questions
Till and McCulloch were not chasing a fashionable “stem cell” brand. Their collaboration began amid Cold War interest in radiation injury and bone marrow recovery. By injecting bone marrow cells into lethally irradiated mice, they noticed discrete nodules—colonies—forming on the spleen. The number of colonies scaled with the number of cells injected, suggesting that rare cells could seed visible outgrowths of blood lineages.
Their landmark 1961 paper in Radiation Research, “A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells,” described this spleen-colony assay and treated the colony-forming units as measurable entities rather than vague metaphors. Follow-up studies with collaborators, including chromosomal-marker work, strengthened the case that many colonies were clonal—descended from single cells—and that some of those cells could both differentiate and renew the colony-forming pool.
For a concise institutional overview of the partnership and its place in Canadian science history, see the Canadian Encyclopedia entry on James Till and related coverage of McCulloch’s career.
What “proof” meant in 1961
Historians of science caution against reading later vocabulary backward. Till and McCulloch initially spoke of colony-forming units, not “stem cells” in today’s textbook sense. Yet the functional criteria they established—rarity, multipotent blood production, and evidence of self-renewal—became the operational backbone of hematopoietic stem cell biology. In other words, they supplied an experimental grammar that later fields could adopt, refine, and sometimes contest.
- Assay over anecdote: colonies could be counted and related to input cell dose.
- Functional definition: behavior in vivo mattered more than a single morphological label.
- Lineage breadth: colonies contained multiple blood cell types, pointing beyond one-lineage progenitors.
A May Clinic Proceedings historical note summarizing their contribution is available via DOI 10.1016/j.mayocp.2021.01.016. The 1961 paper itself is catalogued in scholarly collections such as the University of Toronto’s Scholaris record.
Why this episode sits at the start of the timeline
On an educational site like Stem Cell History, the Till–McCulloch story anchors the timeline for a reason. Later debates about embryonic stem cells, cloning, and induced pluripotency all presume that “stemness” can be demonstrated experimentally. That presumption owes an enormous debt to mid-century hematology. Bone marrow transplantation practices and the language of blood stem cells grew in conversation with the colony-forming tradition, even as molecular markers and purification methods transformed the field.
Joe Sornberger’s book Dreams and Due Diligence later popularized this Canadian research narrative for wider audiences. For readers new to the vocabulary of pluripotency, potency, and niches, our glossary pairs well with this origin story—and the FAQ addresses common mix-ups between hematopoietic stem cells and other stem cell types.
Educational takeaway
The 1961 work did not “invent” regenerative medicine overnight. It did something quieter and more durable: it showed that regenerative capacity in blood could be studied as a countable, falsifiable biological property. That methodological turn is why Till and McCulloch remain landmark figures in the history of stem cell research—long before stem cells became a household phrase.
This article is educational history only. It is not medical advice and does not recommend treatments.